Disclosure of trading in own shares from November 23, 2020 to November 27, 2020
Attachment
Disclosure of trading in own shares from November 23, 2020 to November 27, 2020
Attachment
Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages Paris, November 19, 2026. Sanofi announced today that the European Commission has approved VaxRabeo (rabies virus...
Read MoreSanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease Infilbray is a once-daily oral medicine that acts across the blood-brain...
Read More